{"id":8824,"date":"2026-09-01T08:44:13","date_gmt":"2026-09-01T08:44:13","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?p=8824"},"modified":"2026-09-01T08:44:32","modified_gmt":"2026-09-01T08:44:32","slug":"vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer","status":"publish","type":"post","link":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","title":{"rendered":"Vanguard Life Sciences v\u00e4lkomnar Rebecca Lythe som koncernchef"},"content":{"rendered":"
\"\"<\/figure>\n

Rebecca b\u00f6rjar vid en sp\u00e4nnande tidpunkt i utvecklingen av Vanguard Life Sciences, d\u00e5 vi forts\u00e4tter att bygga vidare p\u00e5 koncernens erfarenhet av att leverera komplex infrastruktur i h\u00e5rt reglerade milj\u00f6er och till\u00e4mpa den expertisen inom l\u00e4kemedels-, bioteknik- och forskningssektorerna.<\/p>\n

Hon har omfattande erfarenhet av strategi, transformation, innovation, styrning och operativt ledarskap. Rebecca b\u00f6rjar p\u00e5 Vanguard efter sju \u00e5r hos Specsavers Group, inklusive mer \u00e4n fyra \u00e5r som VD f\u00f6r Newmedica, d\u00e4r hon ledde tillv\u00e4xten och utvecklingen av en av Storbritanniens ledande leverant\u00f6rer av specialiserad \u00f6gonv\u00e5rd.<\/p>\n

Rebecca har \u00e4ven erfarenhet fr\u00e5n ledande befattningar p\u00e5 Specsavers och ASDA, efter en tidigare karri\u00e4r p\u00e5 KPMG.<\/p>\n

St\u00f6djer n\u00e4sta steg av Vanguard Life Sciences<\/h2>\n

Vanguard Life Sciences, som lanserades 2026, ut\u00f6kar koncernens expertis inom moderna konstruktionsmetoder till avancerade renrum, laboratorier och inneslutningsmilj\u00f6er.<\/p>\n

Vanguard Life Sciences arbetar med organisationer inom l\u00e4kemedels-, bioteknik- och forskningssektorerna och tillhandah\u00e5ller specialiserad infrastruktur utformad f\u00f6r att m\u00f6ta kraven i komplexa och reglerade milj\u00f6er, med fokus p\u00e5 kvalitet, snabbhet och flexibilitet.<\/p>\n

Rebecca sa:<\/p>\n

\n

\u201cVanguard Life Sciences representerar en sp\u00e4nnande m\u00f6jlighet att ta den expertis som Vanguard har byggt upp under mer \u00e4n tv\u00e5 decennier och till\u00e4mpa den i en annan h\u00e5rt reglerad milj\u00f6 d\u00e4r kvalitet, snabbhet och flexibilitet \u00e4r oerh\u00f6rt viktiga.\u201d<\/p>\n<\/blockquote>\n

Som koncernchef kommer Rebecca att leda Vanguard Life Sciences tillsammans med Vanguard Healthcare Solutions<\/a> och koncernens internationella h\u00e4lsov\u00e5rdsverksamhet genom Q-bital Healthcare Solutions<\/a>.<\/p>\n

Hennes utn\u00e4mning kommer samtidigt som Vanguard Life Sciences forts\u00e4tter att etablera sin n\u00e4rvaro inom sektorn och utveckla l\u00f6sningar som kombinerar specialiserad teknisk expertis med f\u00f6rdelarna med moderna byggmetoder.<\/p>\n

Rebecca tillade om de st\u00f6rre m\u00f6jligheterna f\u00f6r koncernen:<\/p>\n

\n

\u201cDet finns betydande potential ut\u00f6ver v\u00e5r etablerade brittiska h\u00e4lsov\u00e5rdsverksamhet. Jag \u00e4r entusiastisk \u00f6ver den fortsatta utvecklingen av Q-bital internationellt och \u00f6ver den m\u00f6jlighet som Vanguard Life Sciences skapar f\u00f6r oss att till\u00e4mpa v\u00e5r erfarenhet av komplexa, reglerade milj\u00f6er p\u00e5 en ny marknad.\u201d<\/p>\n<\/blockquote>\n

Dr Graham Rich, ordf\u00f6rande f\u00f6r Vanguard Healthcare Solutions, sa:<\/p>\n

\n

\u201cRebecca bidrar med en exceptionell kombination av ledarskap inom h\u00e4lso- och sjukv\u00e5rden, strategisk f\u00f6rm\u00e5ga och erfarenhet av att utveckla h\u00f6gkvalitativa kliniska tj\u00e4nster.\u201d.<\/p>\n

\u201c"Jag \u00e4r glad att v\u00e4lkomna Rebecca att leda verksamheten genom n\u00e4sta utvecklingsfas."\u201d<\/p>\n<\/blockquote>\n

Vi \u00e4r glada att v\u00e4lkomna Rebecca till Vanguard-gruppen och ser fram emot n\u00e4sta kapitel f\u00f6r Vanguard Life Sciences n\u00e4r vi forts\u00e4tter att utveckla v\u00e5ra f\u00f6rm\u00e5gor och partnerskap inom l\u00e4kemedels-, bioteknik- och forskningssektorerna.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Vanguard Life Sciences \u00e4r glada att v\u00e4lkomna Rebecca Lythe som VD f\u00f6r Vanguard-gruppen, d\u00e5 hon tilltr\u00e4der rollen fr\u00e5n och med den 1 september 2026.<\/p>","protected":false},"author":11,"featured_media":8825,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8824","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nVanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T08:44:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T08:44:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"chrissybligh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"chrissybligh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"author\":{\"name\":\"chrissybligh\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"headline\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"wordCount\":406,\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\",\"name\":\"chrissybligh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"caption\":\"chrissybligh\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_locale":"sv_SE","og_type":"article","og_title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","og_description":"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_site_name":"Vanguard Life Sciences","article_published_time":"2026-09-01T08:44:13+00:00","article_modified_time":"2026-09-01T08:44:32+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","type":"image\/png"}],"author":"chrissybligh","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"chrissybligh","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"author":{"name":"chrissybligh","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"headline":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"wordCount":406,"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","articleSection":["Uncategorized"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","author":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Livsvetenskap","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Person","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5","name":"chrissybligh","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","caption":"chrissybligh"}}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/posts\/8824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/comments?post=8824"}],"version-history":[{"count":0,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/posts\/8824\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/media\/8825"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/media?parent=8824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/categories?post=8824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/sv_se\/wp-json\/wp\/v2\/tags?post=8824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}